InspireMD Files 8-K, Confirms Nasdaq Listing & Corporate Details
Ticker: NSPR · Form: 8-K · Filed: Jan 31, 2024 · CIK: 1433607
| Field | Detail |
|---|---|
| Company | Inspiremd, INC. (NSPR) |
| Form Type | 8-K |
| Filed Date | Jan 31, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: corporate-governance, regulatory-filing, exchange-listing
TL;DR
**InspireMD filed a routine 8-K, confirming its Nasdaq listing and general corporate info.**
AI Summary
InspireMD, Inc. filed an 8-K on January 31, 2024, primarily to disclose general corporate information and confirm its status as a publicly traded company on The Nasdaq Capital Market LLC under the ticker NSPR. This filing, while not announcing a specific event like an acquisition or earnings, is important for investors as it reaffirms the company's compliance with SEC regulations and its continued listing on a major exchange, providing transparency and stability for current and potential shareholders.
Why It Matters
This filing confirms InspireMD's ongoing compliance with SEC regulations and its listing on The Nasdaq Capital Market, which is crucial for maintaining investor confidence and market liquidity.
Risk Assessment
Risk Level: low — This 8-K is a routine administrative filing and does not introduce new financial or operational risks.
Analyst Insight
A smart investor would view this as a routine compliance filing, confirming the company's operational status and exchange listing, but it doesn't provide new information for investment decisions. It's a good sign of transparency and adherence to regulatory requirements.
Key Numbers
- $0.0001 — Par value per share (This is the nominal value of each common stock share for InspireMD, Inc.)
Key Players & Entities
- InspireMD, Inc. (company) — the registrant filing the 8-K
- The Nasdaq Capital Market LLC (company) — the exchange where InspireMD's common stock is registered
- NSPR (company) — the trading symbol for InspireMD's common stock
- Delaware (company) — state of incorporation for InspireMD, Inc.
- $0.0001 (dollar_amount) — par value per share of common stock
Forward-Looking Statements
- InspireMD, Inc. will continue to be listed on The Nasdaq Capital Market LLC. (InspireMD, Inc.) — high confidence, target: 2025-01-31
FAQ
What is the primary purpose of this 8-K filing by InspireMD, Inc.?
The primary purpose of this 8-K filing, dated January 31, 2024, is to provide current report information pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, including Regulation FD Disclosure and Other Events, and to confirm general corporate details and its listing on The Nasdaq Capital Market LLC.
On which stock exchange is InspireMD, Inc.'s common stock registered?
InspireMD, Inc.'s common stock, with a par value of $0.0001 per share, is registered on The Nasdaq Capital Market LLC under the trading symbol NSPR.
What is the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported in this 8-K filing is January 31, 2024.
What is the state of incorporation for InspireMD, Inc.?
InspireMD, Inc. is incorporated in Delaware, as stated in the filing.
What is the business address of InspireMD, Inc. as listed in the filing?
The business address of InspireMD, Inc. is 4 Menorat Hamaor St., Tel Aviv, Israel, 6744832, with a business phone number of (888) 776-6804.
Filing Stats: 555 words · 2 min read · ~2 pages · Grade level 11.8 · Accepted 2024-01-31 08:09:30
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share NSPR The Nasdaq Capital M
Filing Documents
- form8-k.htm (8-K) — 39KB
- ex99-1.htm (EX-99.1) — 16KB
- ex99-1_001.jpg (GRAPHIC) — 2KB
- 0001493152-24-004411.txt ( ) — 231KB
- nspr-20240131.xsd (EX-101.SCH) — 3KB
- nspr-20240131_lab.xml (EX-101.LAB) — 33KB
- nspr-20240131_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INSPIREMD, INC. Date: January 31, 2024 By: /s/ Craig Shore Name: Craig Shore Title: Chief Financial Officer